Last mentioned: Feb 26, 2026
2026 Outlook
Analysts adjust projections based on Q4 performance and AI integration.
Q4 2025 Earnings Call
Management discusses year-end results and provides guidance for the 2026 fiscal year.
Earnings Release
Avanos, Clarivate, and Leonardo DRS report Q4 2025 results.
Dividend Declaration
Board of Directors declares a $0.09 per share dividend, signaling financial stability.
MDA SHIELD Contract
Leonardo DRS awarded a position on the Missile Defense Agency's SHIELD IDIQ contract.
Q4 Strategy Launch
Companies initiate final quarter strategies for the 2025 fiscal year.
Leonardo DRS and Clarivate reported robust Q4 2025 results, highlighting a surge in demand for integrated defense electronics and AI-driven analytics. These results underscore a broader trend of increased technology spending in mission-critical sectors like national security and intellectual property management.
Leonardo DRS, Inc. reported a strong finish to 2025, buoyed by a record backlog and increased demand for maritime power systems. Meanwhile, Avanos Medical and Clarivate Plc showed resilient results as they navigate sector-specific restructuring and AI integration challenges.
Avanos Medical and Clarivate Plc reported Q4 2025 results highlighting a shift toward high-margin specialized medical devices and AI-driven life sciences analytics. Despite macroeconomic headwinds, these entities demonstrate a sector-wide pivot toward operational efficiency and data-centric healthcare solutions.
Leonardo DRS reported strong Q4 2025 performance, bolstered by critical wins in missile defense and a steady expansion of its naval propulsion business. The company's declaration of a $0.09 dividend reflects growing confidence in its long-term role within the U.S. Navy's submarine modernization programs.